Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2‐deficient mice

Por Zhou, Mei, Learned, R. Marc, Rossi, Stephen J., DePaoli, Alex M., Tian, Hui, Ling, Lei
Publicado no Hepatology (2016)

Biliary Bile Acids in Primary Biliary Cirrhosis: Effect of Ursodeoxycholic Acid

Por Combes, Burton, Carithers, Robert L., Maddrey, Willis C., Munoz, Santiago, Garcia-Tsao, Guadalupe, Bonner, Gregory F., Boyer, James L., Luketic, Velimir A., Shiffman, Mitchell L., Peters, Marion G., White, Heather, Zetterman, Rowen K., Risser, Richard, Rossi, Stephen S., Hofmann, Alan F.
Publicado em 1999

The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents Chronic Hepatitis C

Por Schwarz, Kathleen B., Gonzalez-Peralta, Regino P., Murray, Karen F., Molleston, Jean P., Haber, Barbara A., Jonas, Maureen M., Rosenthal, Philip, Mohan, Parvathi, Balistreri, William F., Narkewicz, Michael R., Smith, Lesley, Lobritto, Steven J., Rossi, Stephen, Valsamakis, Alexandra, Goodman, Zachary, Robuck, Patricia R., Barton, Bruce A.
Publicado em 2010